Edoardo Cignoli : Germany's Merck Cautious After Deal Spree

Germany’s Merck forecasts little or no improvement in earnings this year after a slight drop in fourth-quarter net profit, with stiff competition for its blockbuster multiple-sclerosis treatment and higher research spending likely to offset the impact of recent acquisitions.



via WSJ.com: US Business http://ift.tt/1EcgL0L